Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency

被引:48
作者
Bouillon, R
Koledova, E
Bezlepkina, O
Nijs, J
Shavrikhova, E
Nagaeva, E
Chikulaeva, O
Peterkova, V
Dedov, I
Bakulin, A
Oganov, V
Attanasio, AF
机构
[1] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
[2] Eli Lilly & Co, Kobe, Hyogo, Japan
[3] Eli Lilly & Co, Florence, Italy
[4] Endocrinol Res Ctr, Moscow, Russia
[5] PSI Ltd, St Petersburg, Russia
[6] Russian Acad Sci, Inst Biomed Problems, Space Physiol Dept, State Res Ctr, Moscow, Russia
关键词
D O I
10.1210/jc.2004-0054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consequences of lifelong untreated childhood-onset GH deficiency (COGHD) on adult bone and especially fracture prevalence are largely unknown due to the lack of data on long-term outcome of untreated patients. Therefore, we studied adult Russian patients ( n = 66; 28 females and 38 males) with idiopathic GH-untreated COGHD. Patients had isolated GH deficiency (IGHD; n = 18, age 23 +/- 10 yr) or multiple pituitary hormone deficiency (MPHD) with open (OMPHD; n = 27, age 23 +/- 5 yr) or closed growth plates (CMPHD; n = 21, age 55 +/- 12 yr). Bone mineral content (BMC) and bone mineral density (BMD) values were compared with 821 normal Russian controls. Fracture prevalence was ascertained from medical history and compared with similar data from 333 normal controls. Height SD score was - 4.6 ( range, - 1.8 to - 8.1). This represents 82% of the height of normal Russian adults. BMC of the lumbar spine, femoral neck, and total body of patients with IGHD was 54, 71, and 59%, respectively, of that of age- and sex-matched controls ( all P < 0 0.001). A similarly decreased BMC ( 42 - 69% of expected values) was found for all bone regions of patients with both OMPHD and CMPHD. Mean areal BMD measurements (g/cm(2)) varied (Z scores between - 1.8 and - 3.0), but the calculated true bone density (g/cm(3)) was normal in patients with IGHD or CMPHD and only slightly decreased ( Z score, - 0.8) in patients with OMPHD. Lifetime low-energy fracture prevalence was normal in patients with IGHD but substantially exceeded the expected prevalence in OMPHD ( odds ratio of fracture = 3.0; 0.6 fractures per patient; P < 0.0001) or CMPHD patients ( odds ratio for fracture = 7.4; 2.2 fractures per patient; P < 0.0001). In conclusion, IGHD and MPHD of childhood onset very substantially impair adult height and BMC. Although areal BMD is frankly decreased, volumetric bone density is unaffected, but nevertheless, the fracture prevalence in patients with MPHD is markedly increased. These observations demonstrate that not only volumetric density but also bone mass and shape are major determinants of bone strength.
引用
收藏
页码:4993 / 4998
页数:6
相关论文
共 34 条
[31]   Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study [J].
Vestergaard, P ;
Jorgensen, JOL ;
Hagen, C ;
Hoeck, HC ;
Laurberg, P ;
Rejnmark, L ;
Brixen, K ;
Weeke, J ;
Andersen, M ;
Conceicao, FL ;
Nielsen, TL ;
Mosekilde, L .
CLINICAL ENDOCRINOLOGY, 2002, 56 (02) :159-167
[32]   Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion [J].
Woods, KA ;
Camacho-Hübner, C ;
Bergman, RN ;
Barter, D ;
Clark, AJL ;
Savage, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) :1407-1411
[33]   INCREASED PREVALENCE OF OSTEOPOROSIS AND ARTERIOSCLEROSIS IN PATIENTS WITH CONVENTIONALLY SUBSTITUTED PITUITARY INSUFFICIENCY - IS THERE A NEED FOR ADDITIONAL GROWTH-HORMONE SUBSTITUTION [J].
WUSTER, C ;
SLENCZKA, E ;
ZIEGLER, R .
KLINISCHE WOCHENSCHRIFT, 1991, 69 (16) :769-773
[34]   The infuence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density [J].
Wüster, C ;
Abs, R ;
Bengtsson, BÅ ;
Bennmarker, H ;
Feldt-Rasmussen, U ;
Hernberg-Ståhl, E ;
Monson, JP ;
Westberg, B ;
Wilton, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :398-405